The present invention provides a compound represented by the formula:
wherein the variables R
1
, b, R
6
, Y, Z, X, R and a are defined in the specification. Said compound may be used in a method for treating diseases related to unregulated tyrosine kinase signal transduction, wherein said disease is selected from the group consisting of cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders, and metabolic diseases.
本发明提供的化合物由以下式子表示:其中变量R1、b、R6、Y、Z、X、R和a在规范中定义。所述化合物可用于治疗与未调节的
酪氨酸激酶信号传导相关的疾病的方法,其中所述疾病选自癌症、血管增生性疾病、纤维性疾病、系膜细胞增生性疾病和代谢性疾病等组。